Biontech Se
Clinical trials sponsored by Biontech Se, explained in plain language.
-
New drug BNT142 tested for advanced tumors – early results show promise
Disease control TerminatedThis study tested a new drug called BNT142 in 73 people with advanced solid tumors that have a specific protein (CLDN6). The goal was to see if the drug is safe and how well it works. The study was stopped early, but the results help researchers understand how to treat these hard…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Pancreatic cancer combo trial halted after just one patient
Disease control TerminatedThis study aimed to see if adding the experimental drug BNT321 to standard chemotherapy (mFOLFIRINOX) could help prevent pancreatic cancer from coming back after surgery. It was designed for people whose tumors were completely removed. However, the trial was stopped early after e…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 18, 2026 12:13 UTC